Staar Surgical CoSTAA -5.34%79 Pretax Margin % is 8.79% as of Mar. 2026, which is 69% above its 10-year median of 5.21. GuruFocus rates STAA with a GF Score™ of 79/100 and a GF Value™ of $31.39 (Fairly Valued). The stock has 7 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Staar Surgical Co ranks worse than 60.95% on this metric.
The historical rank and industry rank for Staar Surgical Co's Pretax Margin % or its related term are showing as below:
STAA'
s Pretax Margin % Range Over the Past 10 Years
Min: -34.36 Med: 5.21 Max: 16.02
Current: -6.74
STAA's Pretax Margin % is ranked worse than 60.95% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.61
vs STAA: -6.74
Staar Surgical Co (NAS:STAA) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Staar Surgical Co Pretax Margin % Related Terms
Staar Surgical Co Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Staar Surgical Co's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STAA vs NNNN, ATRC, PLSE: Pretax Margin % Comparison
For the Medical Instruments & Supplies subindustry, Staar Surgical Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Staar Surgical Co Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Staar Surgical Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Staar Surgical Co (STAA) has a Pretax Margin % of 8.79% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Staar Surgical Co and its competitors. This is 69% above median its historical median of 5.21. According to the industry distribution chart, Staar Surgical Co ranks #498 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 61%.
Is Staar Surgical Co's Pretax Margin % too high?
Staar Surgical Co's current Pretax Margin % of 8.79% is 69% above median its 10-year median of 5.21. The Medical Devices & Instruments industry median Pretax Margin % is 2.61. Staar Surgical Co's value of 8.79% is 236.8% above this industry median. Based on the distribution chart, Staar Surgical Co ranks #498 out of 817 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Staar Surgical Co has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Staar Surgical Co's Pretax Margin % compare to NNNN and ATRC?
According to the Medical Devices & Instruments industry distribution chart, Staar Surgical Co ranks #498 out of 817 companies for Pretax Margin %. This places Staar Surgical Co in the lower half of its industry. The industry median Pretax Margin % is 2.61. Staar Surgical Co's value of 8.79% is 236.8% above this benchmark. While the company's 10-year median is 5.21 vs. the industry median of 2.61, Staar Surgical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.61, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Staar Surgical Co's current Pretax Margin % of 8.79% is 236.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Staar Surgical Co and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Staar Surgical Co's current Pretax Margin % is 8.79%, which is 69% above median its own 10-year median of 5.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Staar Surgical Co stock overvalued right now?
Based on GuruFocus' analysis, Staar Surgical Co (STAA) is currently considered Fairly Valued. The stock's GF Value™ is $31.39, compared to a current price of $29.54 — trading 5.9% below its estimated fair value. The current Pretax Margin % is 8.79%, which is 69% above median its 10-year median of 5.21 and 236.8% above the Medical Devices & Instruments industry median of 2.61. Staar Surgical Co's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Staar Surgical Co (STAA), the current Pretax Margin % is 8.79% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Staar Surgical Co (STAA) Overvalued in 2026?
Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued.
The current stock price of $29.54 is trading 5.9% below its estimated GF Value™ of $31.39.
GuruFocus considers Staar Surgical Co to be Fairly Valued.
Key valuation signals for STAA:
Pretax Margin %: 8.79% (69% above median its 10-year median of 5.21)
GF Value™: $31.39 vs. price of $29.54 (5.9% below fair value)
Industry Position: 236.8% above the Medical Devices & Instruments median (#498 of 817)
No single metric tells the full story. See the STAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
79GF Score
Get the complete analysis for STAA
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STAA has been successfully added to your 
